Jacobs Levy Equity Management’s Astrana Health ASTH Stock Holding History

Jacobs Levy Equity Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.58M	Sell	184,901 -201,523	-52%	-$7.25M	0.03%	342
2026 Q1	$9.48M	Sell	386,424 -87,290	-18%	-$2.07M	0.04%	313
2025 Q4	$11.8M	Sell	473,714 -26,813	-5%	-$712K	0.05%	281
2025 Q3	$14.2M	Buy	500,527 +80,465	+19%	+$2.18M	0.06%	247
2025 Q2	$10.5M	Buy	420,062 +182,136	+77%	+$5.13M	0.04%	297
2025 Q1	$7.38M	Buy	237,926 +161,580	+212%	+$5.38M	0.03%	387
2024 Q4	$2.41M	Buy	76,346 +39,156	+105%	+$1.86M	0.01%	565
2024 Q3	$2.15M	Buy	+37,190	New	+$1.83M	0.01%	590

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jacobs Levy Equity Management's ASTH Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Astrana Health (ASTH) stake by 52% in Q2 2026, selling an estimated $7.25M and leaving 184,901 shares worth $8.58M. The position accounts for 0.03% of the portfolio, ranked #342.

Jacobs Levy Equity Management first reported a position in ASTH in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.2M in Q3 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Jacobs Levy Equity Management held 184,901 shares of Astrana Health worth $8.58M as of Q2 2026.
Jacobs Levy Equity Management sold 201,523 Astrana Health shares in Q2 2026, an estimated $7.25M.
Astrana Health made up 0.03% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #342 holding.
Jacobs Levy Equity Management first reported a position in Astrana Health in Q3 2024 and has held it in 8 quarters since.
Jacobs Levy Equity Management's Astrana Health position peaked at $14.2M in Q3 2025.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.